How long can I take Trelstar (triptorelin) for prostate cancer?
Trelstar (triptorelin) can be given for prostate cancer as long as it is tolerated and your doctor believes it is still safe and effective for you, which may be many years. Trelstar is intended as a long-term treatment, and despite the inevitable progression to castration-resistant prostate cancer (CRPC) in most patients receiving androgen deprivation therapies (ADT), such as Trelstar, there may still be benefits in continuing ADT in men in addition to introducing other treatment options for CRPC.
How often is Trelstar given?
For advanced prostate cancer, Trelstar is given intramuscularly (by injection into either buttock) according to the following dosing schedule:
- 3.75 mg every 4 weeks (about once each month)
- 11.25 mg every 12 weeks (about once every 3 months)
- 22.5 mg every 24 weeks (about once every 6 months).
What is Trelstar?
Trelstar may be used in advanced prostate cancer to lower levels of the hormone testosterone in men. Prostate cancer needs the hormone testosterone to grow. Almost all testosterone in men is made by the testicles. Trelstar stops the testicles from making testosterone, reducing testosterone levels, and slowing or stopping the growth of cancer cells. This can help relieve symptoms such as painful or difficult urination.
Related questions
- Why is triptorelin used for prostate cancer?
- What is the strongest chemotherapy drug for breast cancer?
- Which medications make you sleepy?
How does Trelstar work?
Trelstar mimics gonadotropin-releasing hormone (GnRH) and is known as an agonist analog of GnRH. GnRH regulates the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH and FSH are known as gonadotropins because they stimulate the gonads (the testes in males and the ovaries in females) to release hormones. Trelstar causes an initial, transient, surge in FSH, LH, and testosterone, which desensitizes the GnRH receptor through a negative feedback loop causing a sustained decrease in FSH and LH and a significant reduction in the production of testosterone 2 to 4 weeks after initiation.
Trelstar belongs to the class of medications known as gonadotropin-releasing hormone agonists. Trelstar causes serum testosterone concentrations to fall to levels typically observed in surgically castrated men.
References
- Merseburger AS, Hupe MC. An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer. Adv Ther. 2016;33(7):1072-1093. doi:10.1007/s12325-016-0351-4
- Trelstar (triptorelin) Updated 10/2020. Verity Pharmaceuticals Inc. https://www.drugs.com/pro/trelstar.html#s-34068-7
- Triptorelin (Decapeptyl® or Gonapeptyl®) Macmillan Cancer Support. https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/triptorelin#:~:text=Prostate%20cancer%20needs%20the%20hormone,cancer%20or%20stop%20it%20growing.
Read next
Is small cell or non-small cell lung cancer worse?
Generally, small cell lung cancer (SCLC) is worse than non-small cell lung cancer (NSCLC). SCLC accounts for about 10-15% of people who have lung cancer and is the most aggressive form of lung cancer. SCLC usually starts in the breathing tubes (bronchi), and although the cells are small, they grow very quickly and create large tumors. Early on in the course of the disease, there are rarely any symptoms. If caught early (limited-stage disease) 20-25% of people can be potentially cured. Extensive SCLC is more difficult to treat. Continue reading
Is non-small cell lung cancer hereditary?
A hereditary family history of lung cancer is one of the many risk factors for developing non-small cell lung cancer. About 8% of lung cancers are thought to be inherited or linked to gene changes, but smoking and air pollution remain the primary causes of lung cancer. Continue reading
How aggressive is non-small cell lung cancer?
Non-small cell lung cancer (NSCLC) tends to spread more slowly than small cell lung cancer (SCLC). About 80% of all lung cancers are diagnosed as NSCLC. Some forms of NSCLC do grow rapidly, such as large cell undifferentiated carcinoma and large cell neuroendocrine carcinoma. Lung cancer most commonly spreads to the liver, brain, bones or adrenal glands. Continue reading
See also:
Related medical questions
- Does smoking cause non-small cell lung cancer?
- What type of prostate cancer is Erleada used to treat?
- What type of lung cancer is Vizimpro used to treat?
- What type of cancer is Tecentriq used to treat?
- What type of cancer is Daurismo (glasdegib) used to treat?
- How much ibuprofen can I take and how often?
- Does methylene blue kill cancer cells​?
- Oxycodone vs Hydrocodone - How do they compare?
- Does omeprazole cause cancer?
- Why is Xanax so addictive?
- Does Ozempic cause cancer?
- How do you increase platelet count during chemotherapy?
- What are Monoclonal Antibodies and how do they work?
- What medications are known to cause hair loss?
- Vicodin vs Percocet: What's the difference?
- Radiation vs. Chemo: Which cancer treatment is right for you?
- What is Quercetin and what are its health benefits?
- Why give Taxol (Paxel) before carboplatin?
- What is CAR T-cell therapy and how does it work?
- What is the TC chemo regimen and how does it treat breast cancer?
- How do I know if immunotherapy is working?
- What are anti-VEGF drugs (VEGF inhibitors)?
- Treatments for Menopause
- My stool has changed color. What does it mean?
- How do I know if Aldara is working for skin cancer?
Drug information
Related support groups
- Triptorelin (3 questions, 4 members)
- Trelstar (2 questions, 8 members)
- Cancer (197 questions, 645 members)
- Prostate Cancer (60 questions, 158 members)